User name

Don't have a user name yet?
Register here.


Colarič explains Krka's poor results in 2016 for Delo

Ljubljana, 15 July - Krka CEO Jože Colarič has explained for Delo that the critical analysis of the pharma's operations commissioned by the SSH custodian of state assets focused primarily on last year, which was extremely difficult for the company. He stressed that the results in the first half of 2017 were "not only good, but excellent".

Novo mesto
Jože Colarič, the chairman of pharmaceutical company Krka
Photo: Rasto Božič/STA

The rest of this news item is available to subscribers.
The news item consists of 2.550 characters (without spaces) or 517 words words.

Buy the news item. Price: 2 tokens; on account: 0 tokens.

© STA, 2017